Beneficial effects of childhood vaccines for prevention of type 1 diabetes, autoimmune thyroid disease, and celiac disease
儿童疫苗对预防 1 型糖尿病、自身免疫性甲状腺疾病和乳糜泻的有益作用
基本信息
- 批准号:10482378
- 负责人:
- 金额:$ 19.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-06 至 2023-08-31
- 项目状态:已结题
- 来源:
- 关键词:AcuteAddressAffectAutoantibodiesAutoimmune DiseasesAutoimmunityCOVID-19 pandemicCeliac DiseaseChildChildhoodChildhood diabetesChronicChronic DiseaseClinical TrialsComplexConduct Clinical TrialsCongenital Rubella SyndromeDataData SetDatabasesDiabetes MellitusDigestive System DisordersDiseaseEnrollmentEnsureEpidemiologyFamiliarityGoalsHashimoto DiseaseHealth InsuranceImmune responseImmunityImmunizationIncidenceInfantInfectionInsulin-Dependent Diabetes MellitusInsuranceInsurance CoverageIslet CellIslets of LangerhansKidney DiseasesKnowledgeLaboratoriesMeaslesMeasles VaccineMeasles-Mumps-Rubella VaccineMediatingMolecular MimicryMumpsNatural ImmunityObesityObservational StudyParentsPersonsPharmaceutical PreparationsPopulationPreventionPreventive measureProductionReportingRiskRotavirusRotavirus InfectionsRotavirus VaccinesRubellaStatistical Data InterpretationStructure of beta Cell of isletT cell responseT memory cellT-Lymphocyte EpitopesTestingThyroglobulin antibodyTrainingUnited StatesVaccinatedVaccinationVaccinesVirus DiseasesVisitWorkautoimmune thyroid diseasedisorder preventionearly childhoodhigh risklarge datasetspreventprotective effectresponserisk minimizationsafety studysecondary analysisstemunethicalunvaccinatedvaccine hesitancyvaccine refusalvaccine safetyvaccine trial
项目摘要
Viral infections have long been hypothesized to be triggers for childhood autoimmune conditions, but the
benefit of childhood vaccines for prevention of such diseases is uncertain. Studies focusing upon such benefits
are critical due to the rising rates of vaccine deferral in the U.S and the lowered rates of pediatric vaccination
due to the COVID pandemic.
This is a resubmission for
PA-18741 R21 Secondary Analyses in Obesity,
Diabetes and Digestive and Kidney Diseases. Our goal is to examine whether measles, mumps, and rubella
vaccine (MMR) and rotavirus vaccine (RV) protect children from developing 3 associated autoimmune
diseases during childhood: type 1 diabetes (T1D), celiac disease, and autoimmune thyroid disease. Congenital
rubella increases pancreatic islet cell autoantibody production, and we and others have reported that
congenital rubella infection increases risk for T1D. Congenital rubella infection is also associated with anti-
thyroglobulin antibody, a precursor of autoimmune thyroid disease. MMR appears to induce heterologous as
well as trained T-cell responses, thus conferring immunity that is polymicrobial as well as protection against
measles, mumps, and rubella. Therefore, MMR may plausibly protect against triggers for autoimmune disease,
but existing studies are relatively few and underpowered. Along similar lines, we and others have reported that
RV protects against T1D, possibly by interfering with auto-immunization caused by molecular mimicry. Among
persons at high risk for T1D, RV also protects against childhood celiac disease. It is uncertain whether RV
protects against celiac disease in a broad population, and whether RV protects against autoimmune thyroid
disease. To address these knowledge gaps, we propose to examine the protective effects of MMR for
childhood T1D, celiac disease, and autoimmune thyroid disease as well as RV for celiac disease and
autoimmune thyroid disease in the national, longitudinally-integrated health insurance database that we used
in our previous studies (n=1,474,535). Aim 1 is to examine whether MMR decreases risk of early childhood
T1D; we hypothesize that infants who receive MMR will have lower risk compared to unvaccinated infants. Aim
2 is to examine whether MMR and RV decrease risk of early childhood celiac disease. We hypothesize that
infants who receive MMR or RV will have lower risk compared to unvaccinated infants. Aim 3 is to examine
whether MMR and RV decrease risk of early childhood autoimmune thyroid disease. We hypothesize that
infants who receive MMR or RV will have lower risk compared to unvaccinated infants. It is unethical to
conduct clinical trials to establish the impact of vaccines upon autoimmune disease, but studies focusing upon
autoimmune disease prevention are under-powered. Therefore, carefully conducted observational studies are
needed which examine the benefits of vaccines for such diseases. Such benefits may prove to be a compelling
motivator to vaccinate for the vaccine-hesitant. Due to our expertise in epidemiology, statistical analysis of
complex relational data, and familiarity with the datasets, we can efficiently conduct this high-impact work.
长期以来,病毒感染一直被认为是儿童自身免疫性疾病的诱因,但
儿童疫苗对于预防此类疾病的益处尚不确定。研究重点关注这些好处
由于美国疫苗接种推迟率上升以及儿童疫苗接种率下降,这一点至关重要
由于新冠肺炎大流行。
这是重新提交
PA-18741 R21 肥胖的二次分析,
糖尿病、消化系统疾病和肾脏疾病。我们的目标是检查麻疹、腮腺炎和风疹是否
疫苗 (MMR) 和轮状病毒疫苗 (RV) 可保护儿童免受 3 种相关自身免疫性疾病的影响
儿童期疾病:1 型糖尿病 (T1D)、乳糜泻和自身免疫性甲状腺疾病。先天性
风疹会增加胰岛细胞自身抗体的产生,我们和其他人已经报道过
先天性风疹感染会增加患 T1D 的风险。先天性风疹感染也与抗-
甲状腺球蛋白抗体,自身免疫性甲状腺疾病的前兆。 MMR 似乎会诱导异源性
以及训练有素的 T 细胞反应,从而赋予多种微生物的免疫力以及针对
麻疹、腮腺炎和风疹。因此,MMR 可能可以预防自身免疫性疾病的触发因素,
但现有的研究相对较少且力度不够。沿着类似的思路,我们和其他人报告说
RV 可能通过干扰分子拟态引起的自身免疫来预防 T1D。之中
对于 T1D 高危人群,RV 还可以预防儿童乳糜泻。 RV是否还不确定
预防广大人群的乳糜泻,以及 RV 是否可以预防自身免疫性甲状腺
疾病。为了解决这些知识差距,我们建议检查 MMR 对
儿童 T1D、乳糜泻和自身免疫性甲状腺疾病以及 RV 治疗乳糜泻和
我们使用的国家纵向整合健康保险数据库中的自身免疫性甲状腺疾病
在我们之前的研究中(n=1,474,535)。目标 1 是检查 MMR 是否会降低幼儿期风险
T1D;我们假设,与未接种疫苗的婴儿相比,接受 MMR 的婴儿的风险较低。目的
2 是检查 MMR 和 RV 是否降低儿童早期乳糜泻的风险。我们假设
与未接种疫苗的婴儿相比,接受 MMR 或 RV 的婴儿的风险较低。目标 3 是检查
MMR 和 RV 是否可以降低儿童早期自身免疫性甲状腺疾病的风险。我们假设
与未接种疫苗的婴儿相比,接受 MMR 或 RV 的婴儿的风险较低。这是不道德的
进行临床试验以确定疫苗对自身免疫性疾病的影响,但研究重点是
自身免疫性疾病预防力度不足。因此,仔细进行观察性研究
需要检查疫苗对此类疾病的益处。这些好处可能会被证明是令人信服的
对疫苗犹豫不决的人接种疫苗的动机。由于我们在流行病学方面的专业知识,统计分析
复杂的关系数据以及对数据集的熟悉,我们可以有效地开展这项高影响力的工作。
项目成果
期刊论文数量(5)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CATHERINE KIM其他文献
CATHERINE KIM的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CATHERINE KIM', 18)}}的其他基金
Abnormalities in androgens and ovarian markers in reproductive-age racially and ethnically diverse women in a prospective longitudinal cohort
前瞻性纵向队列中不同种族和民族的育龄女性雄激素和卵巢标志物的异常
- 批准号:
10930196 - 财政年份:2023
- 资助金额:
$ 19.5万 - 项目类别:
Gestational diabetes and offspring aging and metabolism
妊娠期糖尿病与后代衰老和代谢
- 批准号:
10425757 - 财政年份:2022
- 资助金额:
$ 19.5万 - 项目类别:
Gestational diabetes and offspring aging and metabolism
妊娠期糖尿病与后代衰老和代谢
- 批准号:
10577849 - 财政年份:2022
- 资助金额:
$ 19.5万 - 项目类别:
Beneficial effects of childhood vaccines for prevention of type 1 diabetes, autoimmune thyroid disease, and celiac disease
儿童疫苗对预防 1 型糖尿病、自身免疫性甲状腺疾病和乳糜泻的有益作用
- 批准号:
10367489 - 财政年份:2021
- 资助金额:
$ 19.5万 - 项目类别:
ReproEDIC: Risk and Progression of Reproductive Abnormalities in Type 1 Diabetes
ReproEDIC:1 型糖尿病生殖异常的风险和进展
- 批准号:
8477599 - 财政年份:2013
- 资助金额:
$ 19.5万 - 项目类别:
Sex Hormones in Postmenopausal Women in the Diabetes Prevention Program
糖尿病预防计划中绝经后妇女的性激素
- 批准号:
7983696 - 财政年份:2010
- 资助金额:
$ 19.5万 - 项目类别:
Sex Hormones in Postmenopausal Women in the Diabetes Prevention Program
糖尿病预防计划中绝经后妇女的性激素
- 批准号:
8098763 - 财政年份:2010
- 资助金额:
$ 19.5万 - 项目类别:
Sex Hormones in Postmenopausal Women in the Diabetes Prevention Program
糖尿病预防计划中绝经后妇女的性激素
- 批准号:
8278068 - 财政年份:2010
- 资助金额:
$ 19.5万 - 项目类别:
A pilot lifestyle intervention for women with histories of GDM: The PEG Study
针对有 GDM 病史的女性的试点生活方式干预:PEG 研究
- 批准号:
7770845 - 财政年份:2009
- 资助金额:
$ 19.5万 - 项目类别:
A pilot lifestyle intervention for women with histories of GDM: The PEG Study
针对有 GDM 病史的女性的试点生活方式干预:PEG 研究
- 批准号:
7637097 - 财政年份:2009
- 资助金额:
$ 19.5万 - 项目类别:
相似国自然基金
时空序列驱动的神经形态视觉目标识别算法研究
- 批准号:61906126
- 批准年份:2019
- 资助金额:24.0 万元
- 项目类别:青年科学基金项目
本体驱动的地址数据空间语义建模与地址匹配方法
- 批准号:41901325
- 批准年份:2019
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
大容量固态硬盘地址映射表优化设计与访存优化研究
- 批准号:61802133
- 批准年份:2018
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
针对内存攻击对象的内存安全防御技术研究
- 批准号:61802432
- 批准年份:2018
- 资助金额:25.0 万元
- 项目类别:青年科学基金项目
IP地址驱动的多径路由及流量传输控制研究
- 批准号:61872252
- 批准年份:2018
- 资助金额:64.0 万元
- 项目类别:面上项目
相似海外基金
Climate Change Effects on Pregnancy via a Traditional Food
气候变化通过传统食物对怀孕的影响
- 批准号:
10822202 - 财政年份:2024
- 资助金额:
$ 19.5万 - 项目类别:
Effects of Aging on Neuronal Lysosomal Damage Responses Driven by CMT2B-linked Rab7
衰老对 CMT2B 相关 Rab7 驱动的神经元溶酶体损伤反应的影响
- 批准号:
10678789 - 财政年份:2023
- 资助金额:
$ 19.5万 - 项目类别:
Functional, structural, and computational consequences of NMDA receptor ablation at medial prefrontal cortex synapses
内侧前额皮质突触 NMDA 受体消融的功能、结构和计算后果
- 批准号:
10677047 - 财政年份:2023
- 资助金额:
$ 19.5万 - 项目类别:
Design and testing of a novel circumesophageal cuff for chronic bilateral subdiaphragmatic vagal nerve stimulation (sVNS)
用于慢性双侧膈下迷走神经刺激(sVNS)的新型环食管套囊的设计和测试
- 批准号:
10702126 - 财政年份:2023
- 资助金额:
$ 19.5万 - 项目类别:
Rapid measurement of novel harm reduction housing on HIV risk, treatment uptake, drug use and supply
快速测量新型减害住房对艾滋病毒风险、治疗接受情况、毒品使用和供应的影响
- 批准号:
10701309 - 财政年份:2023
- 资助金额:
$ 19.5万 - 项目类别: